Erin Harris

Aug 20, 2024 | bioprocessonline.com | Ben Comer |Erin Harris |Dan Schell

In the business of ProFound Therapeutics, Umoja Biopharma, Immunity Bio, Poseida Therapeutics, and more!We're closing in fast on 600,000 downloads of the Business of Biotech podcast, and while that "vanity metric" is fun to watch, it's not what I get most excited about. What gets me excited and puts fuel to the Business of Biotech engine is the interaction with listeners, the feedback, the constructive criticism, the guest suggestions, the picks and the pans.

Jun 18, 2024 | bioprocessonline.com | Louis Garguilo |Erin Harris |Dan Schell |Anna Welch

In the Business of Daiici Sankyo, Vincerx, Mythic Therapeutics, and more!Back-to-back episodes of the Business of Biotech found us talking ADCs with two biotech builders on opposite ends of the continuum last month. On episode 203, Mythic Therapeutics CSO Brian Fiske, Ph.D. painted the picture of his company’s early efforts, focusing on Mythic’s buildout as it develops an ADC pipeline. The following week, Daiichi Sankyo, Inc.